GlpBio

[Leu15]-Gastrin I amide (human) (trifluoroacetate salt)

目录号: GC46361纯度: >95.00%同义词: 15-Leu-Gastrin-17
胃泌素是一种胃肠道激素，其结构类似于羧基末端氨基酸。
[Leu15]-Gastrin I amide (human) (trifluoroacetate salt)
Cas No.: N/A
规格价格库存数量操作
1 mg¥1,448.00现货
1
5 mg¥5,370.00现货
1
10 mg¥9,308.00现货
1
电话: 400-920-5774Email: sales@glpbio.cn

文献被引

本产品暂无引用记录;以下为 GlpBio 产品在 Nature / Cell / Science 等顶刊的客户引用样例
  • Nature cover
    Nature
    641, 529–536 (2025)
  • Nature cover
    Nature
    628, 630–638 (2024)
  • Nature cover
    Nature
    632, 686–694 (2024)
  • Nature cover
    Nature
    618, 1017–1023 (2023)
  • Nature cover
    Nature
    610, 366–372 (2022)
  • Cell cover
    Cell
    187(9):2288-2304 (2024)
  • Cell cover
    Cell
    183(7):1867-1883 (2020)
  • Science cover
    Science
    388(6745) (2025)
  • Science cover
    Science
    387(6739) (2025)
  • Science cover
    Science
    387(6734) (2025)
  • Cell Research cover
    Cell Research
    35, 97–116 (2025)
  • Cell Research cover
    Cell Research
    34, 683–706 (2024)
  • Cell Research cover
    Cell Research
    33, 273–287 (2023)
  • Cell Research cover
    Cell Research
    33, 546–561 (2023)
  • Cell Research cover
    Cell Research
    33, 904–922 (2023)
  • Cell Research cover
    Cell Research
    31, 1291–1307 (2021)

产品描述 Description

Gastrin is gastrointestinal hormones which is structurally similar in carboxy-terminal amino acids[1]. Gastrin are normally produced at high levels by endocrine (G) cells located in the gastric antrum and proximal duodenal mucosa. Gastrin can activate through the CCK2R several signaling pathways that have been linked to proliferation, cell adhesion, and antiapoptotic effects[2]. Human [Leu15]-gastrin-17 is a synthetic analogue of human gastrin-17 and is considered more stable than natural human [Met15]-gastrin-17 while having the same bioactivity[3]

[Leu15]-Gastrin Ⅰ can be synthesized use the Clt-resin[4]. Gastrin analogues can be hydrolyzed by angiotensin-converting enzyme(ACE), indicated that it is possible that administration of ACE inhibitors, used clinically as antihypertensive drugs, could affect the metabolism of gastrin fragments in vivo[5]

Human [Leu15]-gastrin Ⅰ directly modulated secretin binding to its receptors, that may involve in the inhibitory action of secretin on acid secretion induced by gastrin[1]. Continuous infusion of human [Leu15]-gastrin-17 via osmotic minipumps increased the plasma levels of gastrin. In the rats given the high dose(2.4nmol/kg∙h) of human [Leu15]-gastrin-17, the ECL-cell density, the mucosal histamine concentration and HDC activity increased significantly[3]. Continuous infusion of human [Leu15]-gastrin-17(5nmol/kg∙h) for 6 days induces hypergastrinaemia, and caused both vacuoles and lipofuscin bodies to appear in large numbers, suggesting that gastrin stimulates the development not only of vacuoles but also of lipofuscin, perhaps through enhanced autophagocytosis and/or oxidative stress[6]

References:
[1]. Iwakawa S, Nomura H, et al. Direct modulation of secretin binding sites by gastrin in the rat stomach. J Pharmacobiodyn. 1992;15(8):437-441.
[2].Ferrand A, Wang TC. Gastrin and cancer: a review. Cancer Lett. 2006;238(1):15-29.
[3].Ryberg B, Axelson J, et al. Trophic effects of continuous infusion of [Leu15]-gastrin-17 in the rat. Gastroenterology. 1990;98(1):33-38.
[4].Barlos K, Gatos D, et al. Application of 2-chlorotrityl resin in solid phase synthesis of (Leu15)-gastrin I and unsulfated cholecystokinin octapeptide. Selective O-deprotection of tyrosine. Int J Pept Protein Res. 1991;38(6):555-561.
[5].Dubreuil P, Fulcrand P, et al. Novel activity of angiotensin-converting enzyme. Hydrolysis of cholecystokinin and gastrin analogues with release of the amidated C-terminal dipeptide. Biochem J. 1989;262(1):125-130.
[6]. Zhao CM, Chen D, et al. ECL cells of the rat stomach: development of lipofuscin in response to sustained gastrin stimulation. Cell Tissue Res. 1998;291(2):315-323.

实验参考方法 Experimental Reference Method

Cell experiment [1]:

Preparation Method

Enzymic hydrolyses of gastrin analogues were analysed by HPLC Enzyme (0.005 unit) was incubated with substrate (0.1mM) and buffer in a final volume of 0.1mL. Buffer was 100mM-Tris/HCl, pH7.5, containing 0.3M-NaCl. When specific inhibitors of ACE were used, they were preincubated with the enzyme for 5-15min at 37℃. Reactions were carried out at 37℃ for various times and then stopped by freezing in liquid nitrogen. Samples (20μL) were stored at -80℃ before HPLC analysis. In kinetic studies, ACE (0.005 unit) was incubated with gastrin analogues at ten different substrate concentrations (ranging from 10 to 1000μM), in a buffer containing 300mM-NaCl.

Reaction Conditions

10 to 1000μM

Applications

The initial and major site of hydrolysis was the penultimate peptide bond, which generated a major product, the C-terminal amidated dipeptide Asp-Phe-NH2. As a secondary cleavage, ACE subsequently released di- or tri-peptides from the C-terminal end of the remaining N-terminal fragments. Hydrolysis of [Leu15]-gastrin-(14-17)-peptide in the presence of ACE was dependent on the chloride-ion concentration. Km values for the hydrolysis of [Leu15]-gastrin-(11-17)-peptide and [Leu15]-gastrin-(14-17)-peptide at an NaCl concentration of 300mm were respectively 420 and 3280μM, and the catalytic constants were about 115 and 885min-1. The kcat /Km for the reactions at 37℃ was approx. 0.28μM-1min-1. These results suggest that ACE might be involved in the metabolism in vivo of gastrin short fragments.
Animal experiment [2]:

Animal models

Sprague-Dawley rats, weighing 200±225g

Preparation Method

Sprague-Dawley rats were given continuous subcutaneous infusion of human [Leu15]-gastrin-17 (5nmol/kg∙h) via osmotic minipumps, implanted in the neck under anaesthesia for 1, 2 or 6 days

Dosage form

5nmol/kg∙h

Applications

Hypergastrinaemia was induced by continuous infusion of human [Leu15]-gastrin-17 for 6 days. The treatment caused both vacuoles and lipofuscin bodies to appear in large numbers and the vacuoles disappeared promptly after interruption of the hypergastrinaemia, whereas the lipofuscin bodies remained.

References:

[1]. Dubreuil P, Fulcrand P, et al. Novel activity of angiotensin-converting enzyme. Hydrolysis of cholecystokinin and gastrin analogues with release of the amidated C-terminal dipeptide. Biochem J. 1989;262(1):125-130.

[2]. Zhao CM, Chen D, et al. ECL cells of the rat stomach: development of lipofuscin in response to sustained gastrin stimulation. Cell Tissue Res. 1998;291(2):315-323.

产品文档 Product Documents

Purity:>95.00%

化学性质Chemical Properties

CAS 号
N/A
同义词
15-Leu-Gastrin-17
化学名
5-oxo-L-prolylglycyl-L-prolyl-L-tryptophyl-L-leucyl-L-α-glutamyl-L-α-glutamyl-L-α-glutamyl-L-α-glutamyl-L-α-glutamyl-L-alanyl-L-tyrosylglycyl-L-tryptophyl-L-leucyl-L-α-aspartyl-L-phenylalaninamide, trifluoroacetate salt
SMILES
NC([C@H](CC1=CC=CC=C1)NC([C@@H](NC([C@H](CC(C)C)NC([C@@H](NC(CNC([C@@H](NC([C@H](C)NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@H](CC(C)C)NC([C@@H](NC([C@@H]2CCCN2C(CNC([C@@H](N3)CCC3=O)=O)=O)=O)CC4=CNC5=C4C=CC=C5)=O)=O)CCC(O)=O)=O)CCC(O)=O)=O)CCC(O)=O)=O)CCC(O)=O)=O)CCC(O)=O)=O)=O)CC6=CC=C(C=C6)O)=O)=O)CC7=CNC8=C7C=CC=C8)=O)=O)CC(O)=O)=O)=O.FC(F)(C(O)=O)F
分子式
C98H126N20O31.XCF3COOH
分子量
2080.2 g/mol
溶解性
0.1 M NaOH: soluble
保存条件
Store at -20°C
General tips
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。
储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。
为了提高溶解度，请将管子加热至 37°C，然后在超声波浴中震荡一段时间。
Shipping Condition
评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备 RT，或根据请求配备蓝冰。

计算工具摩尔浓度 / 稀释 / 分子量 / 单位换算 / 体内配方 / 溶解度

g/mol